Management and a KOL discuss Gaucher Disease at a virtual event to be held on August 1 at 8:30 am. frln/register.aspx?conf=cc&page=frln&url=https://wsw.com/webcast/cc/frln/1378476′ target= ‘_blank’; rel=’nofollow’>Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FRLN:
- Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease
- Freeline doses first patient in Phase 1/2 GALILEO-1 trial of FLT201
- Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease
- Freeline to Present at 2023 Jefferies Healthcare Conference
- Freeline Reports First Quarter 2023 Financial Results and Business Highlights
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue